PUBLISHED DATE : Feb 2019 | Pages : 183
Fill out your details & get your free sample
U.S. Point-of-care Diagnostics Market Size, Share, & Trends Analysis Report by Product (POC Analyzers and Consumables), Application (Blood Glucose Testing, Cardiovascular and Metabolic Testing, Infectious Disease Testing, Blood Coagulation Testing, Hematology Testing, Cancer Testing, Drugs Of Abuse Testing, and Pregnancy And Fertility/Ovulation Testing), Usage Type (Professional POC Diagnostics and At-Home POC Diagnostics), And End-Users (Professional Healthcare Settings, Home Care, and Others) Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2024
183 Pages
43 Tables
48 Charts
1 Regions
1 Countries
23 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 11 BILLION (2024) |
| CAGR | 7% (2019-2024) |
| Base Year | 2018 |
| Forecast Year | 2019-2024 |
| Market Segments | Product (POC Analyzers and Consumables), Application (Blood Glucose Testing, Cardiovascular and Metabolic Testing, Infectious Disease Testing, Blood Coagulation Testing, Hematology Testing, Cancer Testing, Drugs Of Abuse Testing, and Pregnancy And Fertility/Ovulation Testing), Usage Type (Professional POC Diagnostics and At-Home POC Diagnostics), End-Users (Professional Healthcare Settings, Home Care, and Others |
| Geographic Analysis | North Ameica |
| Countries Covered | The US |
The U.S. Point-of-Care Diagnostics market size will be valued at USD 11 billion in 2024, growing at a CAGR of 7% during 2019-2024. The dynamic changes in the healthcare industry and increasing focus on patient-centered services will propel the demand of point-of-care diagnostics in the US. The implementation of reforms and policies that enable professionals to provide cost-effective and high-quality care to patients is revolutionizing the POCT market. POC testing is emerging as an alternative diagnostic model especially for people residing in remote locations of the country. The increasing awareness about diseases and focus on early diagnosis and disease prevention is contributing to the development of the U.S. point-of-care diagnostics market. The growing popularity of homecare or self-monitoring of diseases, especially self-blood glucose monitoring is contributing to the growth of point-of-care diagnostics distribution network. The advent of remote healthcare & patient monitoring, miniaturization of diagnostic devices, wearable medical devices, and growing usage of smartphones for healthcare applications are some of the key factors contributing to the revenues. The growing popularity of self-testing modules and growth of the in-vitro diagnostics industry will create lucrative opportunities for the leading vendors. The rise in the number of rapid-onset and life-threatening conditions such as sepsis and acute cardiac infarction and will boost demand for POC systems. The ability of POCTs to deliver immediate results thus providing improved patient care will improve, deliver faster and accurate results. This system will also increase the penetration of EMR/HER, remote patient monitoring, self-testing and telehealth . The increasing awareness about disease management and self-monitoring will drive market revenues.
The emergence of wearable medical devices, lab-on-a-chip technology, and growing usage of smartphones is driving the demand for point-of-care devices. The growing availability of rapid tests for diagnosing infectious diseases like HIV, TB or malaria, that enable physicians and patients to visualize the results from a smartphone and take appropriate clinical decisions will transform the market over the next few years.
The recent development of microfluidic-based POC devices will transform the U.S. point-of-care diagnostics market during the forecast period. The rising application of microfluidic technologies to develop and commercialize advanced clinical diagnostic analyzers will lead to the launch of innovative POC systems. Some of the most commonly used microfluidics-based analyzers are blood chemistries, nucleic-acid amplification tests, immunoassays, and flow cytometry. This process used the ability to extensive use of complex multiplexing approaches and formats, the capacity for inclusion of sequential sample pre-conditioning steps of different types, reagent storage, the use of multiple steps involving reagent addition, mixing and washing, the potential for incorporation of centrifugal steps at various speeds, and the application of a range of detection strategies leading to greater sensitivity and clarity of results. The growing use of POC systems in ambulatory care and physician offices for accurate clinical decision making will contribute to the profitability in the market.
This market research report includes detailed market segmentation by
Consumables segment dominated more than half of the total share in 2018, growing at a CAGR of approximately 8% during the forecast period. The increasing use of various rapid tests across emergency care, physician offices, ambulatory settings, nursing homes, and by individuals for diagnosing various diseases is propelling the growth of this segment. The rapid tests are used for diagnosing diseases such as infectious diseases, diabetes, cancer, and other metabolic diseases. The vendors are offering a diverse range of consumables catering to end-user requirements and that are patient-center approaches to gain the maximum consumers. Some of the most common POC consumables available in the U.S. point-of-care diagnostics market are reagents, immunodiagnostic test kits, blood glucose test strips, and pregnancy and fertility test kits.
The growing incidences of various acute and chronic diseases such as cardiovascular diseases, hepatitis, HIV, cancer, chronic kidney disease, diabetes, and sexually transmitted diseases (STDs) is boosting the demand for POC analyzers. The introduction of automated and compact POC analyzers that help improve the efficiency and quality of the operations will drive the demand for these devices in the U.S. point-of-care diagnostics market.
The application segment in the U.S. point-of-care diagnostics market is classified into blood glucose testing, cardiovascular and metabolic testing, infectious disease testing, blood coagulation testing, hematology testing, cancer testing, drugs of abuse testing, and pregnancy and fertility/ovulation testing. Infectious disease testing is the fastest growing technology segment, at a CAGR of around 11% during the forecast period. The launch of POC diagnostics and rapid test kits providing accurate and quick diagnostics is propelling the growth of this segment. The use of these rapid tests will help reduce the use of unnecessary antibiotics and result in the cost-effective and quick decision-making process in the market. Leading point-of-care diagnostics companies such as Roche Diagnostics is offering advanced POC analyzers for infectious disease testing and boosting the demand in the U.S. point-of-care diagnostics market.
The rapid adoption of various self-testing blood glucose devices that offer portability and convenience will augment the development of the US market. The growing demand for POC cardiometabolic testing will enable easy disease management and monitor cardiometabolic conditions such as cardiac markers, lipid analysis, blood gases, HbA1C, and cholesterol levels on a real-time basis. The vendors are introducing a broad range of rapid test for cancer screening and detection for reliable, fast, and non-invasive tests to gain larger shares.
The professional healthcare segment occupied more than half of the total share in 2018, growing at a CAGR of around 7% during the forecast period. The increasing use of point-of-care diagnostics technology for detecting of acute and chronic diseases is fueling the growth of this segment. The increasing incidences of chronic illnesses, such as diabetes, HIV, cancer, and heart diseases and acute diseases like sepsis, respiratory tract infections (RTIs), and antibiotic resistance is driving the demand for these services. The increasing use of medical diagnosis, biosensors, and point-of-care testing devices is augmenting the development of this segment. The government initiatives aimed to promote the use of point-of-care diagnostic tests will boost revenues over the next few years.
The increasing use of self-monitoring devices and test kits as an early symptom management tool and to manage high-risk chronically ill patients will drive the growth of the home care segment. These test kits also find applications across the academic and research institutes, military, and non-profit organizations in the U.S. point-of-care diagnostics market.
At-home POC diagnostic is the fastest growing segment, at a CAGR of more than 7% during the forecast period. The cost-effective and quick results of this procedure are augmenting the growth of this segment. The increasing availability of self-testing kits available for diagnosing UTIs and other acute infections, assess fertility by way of ovarian egg reserve, and check for STDs is contributing to the development of the at-home care setup. These tests are designed to offer quick, cost-effective, and confidential information at the convenience of the patient’s home. The increasing awareness about the self-testing and screening kits will contribute to the major revenues.
The professional healthcare setup consists of physician office labs, clinics, emergency care centers, critical care in hospitals, nursing homes, community care centers, home care centers like geriatric and pediatric care centers. The increasing launch of many innovative and compact POC analyzers and the rapid test will contribute to the growing revenues in the U.S. point-of-care diagnostics market shares.
The market is highly dynamic due to the presence of several international and regional players operating in the region. The vendors are offering a diverse range of analyzers and kits to attract the maximum number of consumers in the US market. Strategical partnerships and consolidation will positively impact the development of the competitive landscape in the US. Effective strategies such as the expansion of product offerings, accessing new technology, and increasing share will help companies survive the intense competition in the market.
Major vendors:
By Product
By Application
By Usage
By End-users
Frequently Asked Questions
What is the U.S. point-of-care diagnostics market size and growth rate during the forecast period?
U.S. POINT-OF-CARE DIAGNOSTICS MARKET SIZE WILL REACH USD 11 BILLION BY 2024, GROWING AT A CAGR OF 7% DURING 2019-2024
What are the factors impacting the growth of the U.S. point-of-care diagnostics market shares?
The US point-of-care diagnostics market is driven by the latest innovations in the diagnostics industry is to provide an expedited diagnosis for quick clinical decision making to support treatment regimens.
Which product/application/end-user is generating the largest revenues for the U.S. market?
The consumables segment dominated more than half of the total share in 2018, growing at a CAGR of approximately 8% during the forecast period.
The leading vendors in the US POC diagnostic market are Abbott, F. Hoffmann-La Roche, and Siemens Healthineers
At-home POC diagnostic is the fastest-growing segment, at a CAGR of more than 7% during the forecast period. The cost-effective and quick results of this procedure are augmenting the growth of this segment.
The US point-of-care diagnostics market size is expected to reach revenues of approximately $11 billion by 2024, growing at a CAGR of over 7% 2019–2024.
The US point-of-care diagnostics market is driven by the latest innovations in diagnostics industry is to provide an expedited diagnosis for quick clinical decision making to support treatment regimens. The growing need to deliver quantitative lab-quality results and transfer to an information system, or a healthcare professional, or store as an electronic medical record for future analysis and interpretation will drive the demand for new technologies in the US point-of-care diagnostics market. The market research report provides in-depth market analysis and segmental analysis of the US point-of-care diagnostics market by product, technology, usage type, and end-users.
Base Year: 2018
Forecast Year: 2019–2024
The report considers the present scenario of the US point-of-care diagnostics market and its market dynamics for the period 2019−2024. It covers a detailed overview of various market growth enablers, restraints, and trends. The report segments the market based on the product type (POC analyzers and consumables); application type (blood glucose testing, cardiovascular and metabolic testing, infectious disease testing, blood coagulation testing, hematology testing, cancer testing, drugs of abuse testing, and pregnancy and fertility/ovulation testing); usage type (professional POC diagnostics and at-home POC diagnostics) and end-user type (professional healthcare settings, home care, and others), while elaborating the present market scenario and discussing the futuristic demand in the market for POC diagnostics. It also profiles and analyzes the leading companies and various other prominent companies operating in the market. The report also discusses the future market growth, improvement areas, and strategic recommendations for the US point-of-care diagnostics market vendors.
Major Vendors in the US Point-of-Care Diagnostics Market
Key companies to Watch in the US Point-of-Care Diagnostics Market
Prominent Players in the US Point-of-Care Diagnostics Market
Market Segmentation by Product
Market Segmentation by Application
Market Segmentation by Usage
Market Segmentation by End-users
1 Research Methodology
2 Research Objectives
3 Research Process
4 Report Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope of Study
4.3.1 US Point-of-care Diagnostics Market Segmentation by Product Types
4.3.2 US Point-of-care Diagnostics Market Segmentation by Application Types
4.3.3 US Point-of-care Diagnostics Market Segmentation by Usage
4.3.4 US Point-of-care Diagnostics Market Segmentation by End-user Types
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Inclusions
5.3 Exclusions
5.4 Currency Conversion
5.5 Market Derivation
6 Market at a Glance
7 Introduction
7.1 POC: An Overview
8 Market Dynamics
8.1 US Point-of-care Diagnostics Market Growth Enablers
8.1.1 Increase in Prevalence/Incidence of Several Acute and Chronic Diseases
8.1.2 New Product Approvals/Launches
8.1.3 Increasing Number of CLIA Waiver POC Tests
8.1.4 High Focus on Early Diagnosis and Disease Prevention
8.1.5 Vendors’ Focus on Manufacturing Innovative POC Platforms for Existing and New Applications
8.1.6 YOY Impact of Market Growth Enablers
8.2 US Point-of-care Diagnostics Market Growth Restraints
8.2.1 Time Consuming and Stringent Regulations for Approvals of POC Diagnostics
8.2.2 Limitations and Data Accuracy Challenges with POC Diagnostics
8.2.3 YOY Impact of Market Growth Restraints
8.3 US Point-of-care Diagnostics Market Opportunities & Trends
8.3.1 Growing Demand for POC Molecular Diagnostic Testing
8.3.2 High Growth Potential for Multiplexed POC Diagnostic Testing (xPOCT)
8.3.3 Strategic Acquisitions
8.3.4 Robust Pipeline and Investigational POC Diagnostic Devices
8.3.5 Development of Microfluidic-based POC devices
8.3.6 YOY Impact of Market Opportunities & Trends
9 US Point-of-care Diagnostics Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Porter’s Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry
10 US Point-of-care Diagnostics Market by Product
10.1 Market Overview
10.2 Consumables
10.2.1 Market Overview
10.2.2 Market Size & Forecast
10.3 POC Analyzers/Instruments
10.3.1 Market Overview
10.3.2 Market Size & Forecast
11 US Point-of-care Diagnostics Market by Application
11.1 Market Overview
11.2 Blood Glucose Testing
11.2.1 Market Overview
11.2.2 Market Size & Forecast
11.3 Cardiovascular and Metabolic Testing
11.3.1 Market Overview
11.3.2 Market Size & Forecast
11.4 Infectious Disease Testing
11.4.1 Market Overview
11.4.2 Market Size & Forecast
11.5 POC Blood Coagulation Testing
11.5.1 Market Overview
11.5.2 Market Size & Forecast
11.6 POC Hematology Testing
11.6.1 Market Size & Forecast
11.7 POC Cancer Testing
11.7.1 Market Overview
11.7.2 Market Size & Forecast
11.8 POC Drugs of Abuse Testing
11.8.1 Market Size & Forecast
11.9 Pregnancy and Fertility/Ovulation Testing
11.9.1 Market Size & Forecast
12 US Point-of-care Diagnostics Market by End-user
12.1 Market Overview
12.2 Professional Healthcare Settings
12.2.1 Market Overview
12.2.2 Professional Healthcare Settings: Market Size & Forecast
12.2.3 Hospitals and Laboratories: Market Size & Forecast
12.2.4 Ambulatory Care Settings: Market Size & Forecast
12.2.5 Emergency Care/Urgent Care Centers: Market Size & Forecast
12.3 Home Care
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Other End-users
12.4.1 Market Size & Forecast
13 US Point-of-care Diagnostics Market by Prescription
13.1 Market Overview
13.2 Professional POC Diagnostics
13.2.1 Market Size & Forecast
13.3 At-home/OTC-based POC
13.3.1 Market Size & Forecast
14 Competitive Landscape
14.1 Market overview
14.2 Market Vendor Share/Ranking Analysis
15 Key Company Profiles
15.1 Abbott
15.1.1 Business Overview
15.1.2 Abbott in US Point-of-care Diagnostics Market
15.1.3 Major Product Offerings
15.1.4 Key Strategies
15.1.5 Key Strengths
15.1.6 Key Opportunities
15.2 F. Hoffmann-La Roche
15.2.1 Business Overview
15.2.2 F. Hoffmann-La Roche in US Point-of-care Diagnostics Market
15.2.3 Major Product Offerings
15.2.4 Key Strategies
15.2.5 Key Strengths
15.2.6 Key Opportunities
15.3 Siemens Healthineers
15.3.1 Business Overview
15.3.2 Siemens Healthineers in US Point-of-care Diagnostics Market
15.3.3 Major Product Offerings
15.3.4 Key Strategies
15.3.5 Key Strengths
15.3.6 Key Opportunities
16 Key Companies to Watch
16.1 Danaher
16.1.1 Business Overview
16.1.2 Danaher in US Point-of-care Diagnostics Market
16.1.3 Product Offerings
16.1.4 Key Strategies
16.1.5 Key Strengths
16.1.6 Key Opportunities
16.2 LifeScan
16.2.1 Business Overview
16.2.2 Product Offerings
16.2.3 Key Strategies
16.2.4 Key Strengths
16.2.5 Key Opportunities
16.3 Ascensia Diabetes Care Holdings
16.3.1 Business Overview
16.3.2 Product Offerings
16.3.3 Key Strategies
16.3.4 Key Strengths
16.3.5 Key Opportunities
16.4 BD
16.4.1 Business Overview
16.4.2 BD in US Point-of-care Diagnostics Market
16.4.3 Product Offerings
16.4.4 Key Strategies
16.4.5 Key Strengths
16.4.6 Key Opportunities
16.5 Quidel
16.5.1 Business Overview
16.5.2 Quidel in US Point-of-care Diagnostics Market
16.5.3 Product Offerings
16.5.4 Key Strategies
16.5.5 Key Strengths
16.5.6 Key Opportunities
17 Other Prominent Vendors
17.1 Abaxis
17.1.1 Business Overview
17.1.2 Product Offerings
17.2 ACON Laboratories
17.2.1 Business Overview
17.2.2 Product Offerings
17.3 AgaMatrix
17.3.1 Business Overview
17.3.2 Product Offerings
17.4 Arbor Vita
17.4.1 Business Overview
17.4.2 Product Offerings
17.5 bioMérieux
17.5.1 Business Overview
17.5.2 Product Offerings
17.6 Chembio Diagnostic Systems
17.6.1 Business Overview
17.6.2 Product Offerings
17.7 EKF Diagnostics USA (Stanbio Laboratory)
17.7.1 Business Overview
17.7.2 Product Offerings
17.8 Exact Sciences
17.8.1 Business Overview
17.8.2 Product Offerings
17.9 Instrumentation Laboratory
17.9.1 Business Overview
17.9.2 Product Offerings
17.10 Meridian Bioscience
17.10.1 Business Overview
17.10.2Product Offerings
17.11 Sekisui Diagnostics
17.11.1 Business Overview
17.11.2Product Offerings
17.12 Sinocare
17.12.1 Business Overview
17.12.2Product Offerings
17.13 Sysmex America
17.13.1 Business Overview
17.13.2Product Offerings
17.14 Swiss Precision Diagnostics
17.14.1 Business Overview
17.14.2Product Offerings
17.15 Trinity Biotech
17.15.1 Business Overview
17.15.2Product Offerings
18 Report Summary
18.1 Key Takeaways
18.2 Strategic Recommendations
18.3 Qualitative Summary
18.4 Quantitative Summary
18.4.1 Market by Application
18.4.2 Market by Product
18.4.3 Market by Usage Type
18.4.4 Market by End-users
19 Appendix
19.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of US Point-of-care Diagnostics Market
Exhibit 2 Market Size Calculation Approach 2018
Exhibit 3 Diagnosis Steps Involved in Non-waived and CLIA-waived Diagnostic Testing
Exhibit 4 Advantages of Early Diagnosis and Prevention
Exhibit 5 Major POC Diagnostic Testing Limitations
Exhibit 6 Common Errors in POC Diagnostic Tests
Exhibit 7 US Point-of-care Diagnostics Market 2018–2024 ($ million)
Exhibit 8 Five Forces Analysis 2017
Exhibit 9 US Market by Product Type
Exhibit 10 US Market 2018 and 2024 (%)
Exhibit 11 US Point-of-care Diagnostics Market 2018−2024 ($ million)
Exhibit 12 US Market by POC Test Kits/Consumables 2018–2024 ($ million)
Exhibit 13 US Market by Analyzers/Instruments 2018–2024
Exhibit 14 US Market by Application Type
Exhibit 15 US Point-of-care Diagnostics Market by Application 2018 and 2024 (%)
Exhibit 16 US Market by Application 2018−2024 ($ million)
Exhibit 17 US Market by Blood Glucose Testing 2018–2024 ($ million)
Exhibit 18 US Market by Cardiometabolic Testing 2018–2024 ($ million)
Exhibit 19 US Market by Infectious Disease Testing 2018–2024 ($ million)
Exhibit 20 US Point-of-care Diagnostics Market by Blood Coagulation Testing 2018–2024 ($ million)
Exhibit 21 US Market by Hematology 2018–2024 ($ million)
Exhibit 22 US Market by Cancer Testing 2018–2024 ($ million)
Exhibit 23 US Point-of-care Diagnostics Market by Drugs of Abuse Testing 2018–2024 ($ million)
Exhibit 24 US Market by Pregnancy and Fertility/Ovulation Testing 2018–2024 ($ million)
Exhibit 25 US Market by End-user
Exhibit 26 US Market 2018 and 2024 (%)
Exhibit 27 US Point-of-care Diagnostics Market by End-user 2018−2024 ($ million)
Exhibit 28 US Market by Professional Healthcare Settings 2018 (%)
Exhibit 29 US Market by Professional Healthcare Settings 2018−2024 ($ million)
Exhibit 30 US Market by Professional Healthcare Settings 2018−2024 (%)
Exhibit 31 US Market by Professional Healthcare Settings 2018–2024 ($ million)
Exhibit 32 US Market by Hospitals and Laboratories 2018–2024 ($ million)
Exhibit 33 US Market by Ambulatory Care Settings 2018–2024 ($ million)
Exhibit 34 US Market by Emergency Care/Urgent Care Centers 2018–2024 ($ million)
Exhibit 35 US Market by Home Care 2018–2024 ($ million)
Exhibit 36 US Market by Other End-users 2018–2024 ($ million)
Exhibit 37 US Market by Usage Type
Exhibit 38 US Market by Usage Type 2018 & 2024 (%)
Exhibit 39 US Market by Usage Type 2018−2024 ($ million)
Exhibit 40 US Point-of-care Diagnostics Market by Usage Type 2018−2024 (%)
Exhibit 41 Prescription-based US Point-of-care Diagnostics Market 2018−2024 ($ million)
Exhibit 42 At-home/OTC-based US Point-of-care Diagnostics Market 2018−2024 ($ million)
Exhibit 43 Abbott Sales Breakdown by Segments 2017
Exhibit 44 F. Hoffmann-La Roche Sales Breakdown by Divisions 2017
Exhibit 45 Siemens Healthineers Revenue Breakdown by Business Segments 2017 (%)
Exhibit 46 Danaher Sales Breakdown by Business Segments 2017 (%)
Exhibit 47 Danaher Business Segments R&D Expenditure 2017 (%)
Exhibit 48 Quidel Revenue Breakdown by Product Categories 2017 (%)
List of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2017
Table 3 Recent Product Approvals in US Point-of-care Diagnostics Market
Table 4 Tests Granted CLIA-waived Status by CMS and their CPT Codes Recently
Table 5 Few Popular Innovative POC Diagnostics Available in US
Table 6 YOY Impact of Market Growth Enablers 2018−2024
Table 7 YOY Impact of Market Growth Restraints 2018−2024
Table 8 Popular POC Molecular Diagnostics and Tests in US
Table 9 xPOCT Systems Available in US
Table 10 Recent Acquisitions in Point-of-care Diagnostics Market
Table 11 US Point-of-care Diagnostics Market: Pipeline Devices and Tests
Table 12 Microfluidic-based POC Devices Under Investigation
Table 13 YOY Impact of Market Opportunities & Trends 2018−2024
Table 14 Popular Blood Glucose Meter Brands in US
Table 15 US Point-of-care Diagnostics Market: Vendors Ranking
Table 16 Abbott: Product Offerings
Table 17 F. Hoffmann-La Roche: Product Offerings
Table 18 Siemens Healthineers: Product Offerings
Table 19 Danaher: Product Offerings
Table 20 LifeScan: Product Offerings
Table 21 Ascensia Diabetes Care: Product Offerings
Table 22 BD: Product Offerings
Table 23 Quidel: Product Offerings
Table 24 Abaxis: Product Offerings
Table 25 ACON Laboratories: Product Offerings
Table 26 AgaMatrix: Product Offerings
Table 27 Arbor Vita: Product Offerings
Table 28 bioMérieux: Product Offerings
Table 29 Chembio Diagnostic Systems: Product Offerings
Table 30 EKF Diagnostics: Product Offering
Table 31 Exact Sciences: Product Offerings
Table 32 Instrumentation Laboratory: Major Product Offerings
Table 33 Meridian Bioscience: Product Offerings
Table 34 Sekisui Diagnostics: Product Offerings
Table 35 Sinocare: Product Offerings
Table 36 Sysmex America: Product Offerings
Table 37 Swiss Precision Diagnostics: Product Offerings
Table 38 Trinity Biotech: Product Offerings
Table 39 Qualitative Summary of US Point-of-care Diagnostics Market
Table 40 US Market by Application 2018–2024
Table 41 US Market by Product Types 2018–2024
Table 42 US Market by Prescription Types 2018–2024
Table 43 US Point-of-care Diagnostics Market by End-user 2018–2024
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
